Back to Directory
Last Updated: 06/05/2026

Abzena

Cambridge
Founded 2014
CDMO and CRO for complex biologics and bioconjugate development

Abzena is an integrated CDMO and CRO specialising in complex biologics and bioconjugates, with cGMP facilities across the United States and a research presence in Cambridge, UK.

Its services span antibody discovery, cell line development, bioconjugation and GMP manufacturing across monoclonal antibodies, antibody-drug conjugates, bispecifics and fusion proteins, with site-specific conjugation technology enabling homogeneous conjugates with controlled drug-to-antibody ratios.

Abzena serves biotech and pharmaceutical clients from discovery through commercial launch.